AIP mutations lead to pituitary adenomas that have a distinctive clinical profile with a significantly younger onset, more aggressive tumor growth and larger tumor diameter at diagnosis, as compared with non-AIP-associated pituitary tumors [11]. The gene discussed is AIP; the disease is neoplasm.